Drug Profile


Alternative Names: ERB-041; WAY-202041

Latest Information Update: 10 Aug 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Wyeth
  • Class Antirheumatics; Benzoxazoles; Small molecules
  • Mechanism of Action Selective estrogen receptor beta agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Crohn's disease; Endometriosis; Interstitial cystitis; Rheumatoid arthritis

Most Recent Events

  • 16 Oct 2008 Discontinued - Phase-I for Endometriosis in Japan (PO)
  • 16 Oct 2008 Discontinued - Phase-II for Endometriosis in Australia (PO)
  • 16 Oct 2008 Discontinued - Phase-II for Endometriosis in Belgium (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top